MP49-03 DOES SCHEDULED ALVIMOPAN, ACETAMINOPHEN AND GABAPENTIN IMPROVE SHORT-TERM CLINICAL OUTCOMES AFTER RETROPERITONEAL LYMPH NODE DISSECTION?: A PILOT STUDY | Zendy

AI Assistant Blog Pricing

MP49-03 DOES SCHEDULED ALVIMOPAN, ACETAMINOPHEN AND GABAPENTIN IMPROVE SHORT-TERM CLINICAL OUTCOMES AFTER RETROPERITONEAL LYMPH NODE DISSECTION?: A PILOT STUDY

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.